AzTrials
AzTrials

StrokeNCT00107068

Exercise Training and Walking Ability After Chronic Stroke

A study testing [A] Aerobic isokinetic cycling exercise, [B] Progressive Resistance Training and [A] + [B] in people with Stroke, run by University of Sydney at 1 site in Australia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will investigate the efficacy of aerobic exercise and progressive resistance training (PRT), singularly and combined, on changes in walking endurance for mildly-to-moderately affected chronic stroke patients. Read more about this study

Who is it for?
Ages 45 to 90 years
Conditions the study is for
Stroke
What is being tested?
[A] Aerobic isokinetic cycling exercise, [B] Progressive Resistance Training and [A] + [B]
Type of treatment
Surgery or procedure
How many people
48 participants
Where
1 siteAustralia
Study dates
Jan 2001to May 2004
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age > 45 years
  • First stroke resulting in hemiplegia
  • At least 4-months post stroke
  • Residing at home or community-based (non-institutionalized) living environment
  • Self selected gait velocity between 0.42 m/s to 0.80 m/s
  • No longer receiving physiotherapy.
  • Adequate comprehension of instructions and perceptual abilities (assessed by stroke clinician during medical screening), no significant musculotendinous or bony restrictions of the affected limb, nor any serious chronic disease independently causing significant disability or profound atrophy of the affected limb will comprise further indications to participation

Who cannot join

  • Subjects will be excluded if they have significant cardiac disease, symptom limiting peripheral vascular disease, or any of the exclusion criteria contraindicating moderate exercise as outlined by the American College of Sports Medicine guidelines for cardiac disease rehabilitation or for frail and elderly adults. The initial symptom-limited/maximal aerobic assessment will serve as the screening test for contraindications to further exercise.

Trial locations and contacts

1 site in 1 country.

Australia1 site
  • Rehabilitation Research Centre, University of Sydney

    Sydney, New South Wales, 2141

Other trials in Australia

About this study

Official title: Does Aerobic or Resistance Exercise Training Improve Walking Ability in Chronic Stroke Patients?

This study will investigate the efficacy of aerobic exercise and progressive resistance training (PRT), singularly and combined, on changes in walking endurance for mildly-to-moderately affected chronic stroke patients. Specifically, we will determine the relative importance of training induced changes in muscle strength versus aerobic fitness on increases in gait velocity and 6-min walking distance, and assess the concomitant functional and psychosocial impact of increased muscle strength, aerobic fitness and improved gait. This longitudinal study will be conducted as a double blinded factorial randomized controlled trial of exercise training for chronic stroke patients.

Read the detailed description

The experimental hypotheses are:

  1. Participation in a 10-week exercise program consisting of aerobic, resistance or combined aerobic+resistance training will produce a 20% or greater increase of 6-min walking distance compared to controls.
  2. Aerobic fitness will increase equally in the combined aerobic+resistance program and aerobic program alone, greater than that in the resistance program only, where effect is measured in terms of maximal and submaximal cardiorespiratory exercise performance.
  3. Lower limb muscle strength will increase equally in the combined aerobic+resistance program and resistance program alone, greater than the increase in strength for aerobic training, where effect is measured in terms of measures of lower limb strength, power and endurance.

Research Plan Synopsis:

To determine treatment efficacy, a 2x2 factorial double-blinded randomized controlled trial will be conducted, the two factors being aerobic training and PRT. Forty-eight subjects will be randomly allocated to one of four groups comprising (i) aerobic exercise training [AEROBIC; n=12]; (ii) PRT [RESISTANCE; n=12]; (iii) combined aerobic training and PRT [AEROBIC+RESISTANCE; n=12], or (iv) control [CONTROLS; n=12]. AEROBIC and RESISTANCE groups will also include a "sham" treatment for the other factor, and the order of presentation of treatment versus "sham" will also be randomized within each exercise session. All subjects will attend 3 times per week for 10 weeks. Subjects will be recruited from various hospitals, peer support groups and previous participants of an acute stroke research project that we are now conducting. All will be screened by a medical practitioner for inclusion and exclusion criteria and then allocated to one of the four groups by the trial coordinator.

Interventions:

AEROBIC Training Group: These subjects will undertake 30 min of leg cycling per exercise session. Leg cycling will be performed at a pedaling cadence of 50 rev/min in the seated posture using a standard seated cycle ergometer to elicit a target heart rate equivalent to 50% VO2peak - 70% VO2peak. Subjects in this group will also undertake 30-min of "sham" resistance training consisting of stretching and calisthenics lacking any strength development characteristics. Cycle ergometry will be used to develop aerobic fitness, rather than fast walking, because previous studies have shown that stroke patients do not have the capacity to walk at a sufficient pace to provide an adequate stimulus to the cardiovascular system.

RESISTANCE Training Group: These subjects will undertake 30 min of PRT per exercise session using pneumatic resistance equipment and free weights. Standard PRT principles governing frequency, volume, duration, and intensity of exercise known to provide maximal adaptation in both healthy and frail adults will be followed. Legs will be trained unilaterally to maximize neural recruitment of the impaired side and prevent substitution of stronger muscles for weaker ones. Subjects will perform 3 sets of 8 repetitions at 80% of the one repetition maximum with each muscle group. Subjects in this group will also undertake 30-min of "sham" aerobic training consisting of motorized passive leg cycling.

AEROBIC+ RESISTANCE Training Group: Subjects in the AEROBIC+RESISTANCE training group will undertake 30 min of leg cycling exercise as described for the AEROBIC group in addition to 30 min of PRT as described for the RESISTANCE group per exercise session.

CONTROL Group: Subjects in this group will undertake 30-min of "sham" aerobic training consisting of motorized passive leg cycling and 30-min of "sham" resistance training consisting of stretching and calisthenics lacking any strength development characteristics per session.

Outcomes:

Primary outcome: Subjects will undertake a 6 min walking test for maximum distance. The 6-min test has been selected as our primary outcome because walking distance is an important criteria for 'community ambulation', it avoids the problem of gait velocity being relevant only for short-distance ambulation and has a prior history of investigation in previous studies of low intensity aerobic and resistance training.

Secondary outcomes:

  1. Cardiorespiratory Fitness will be assessed from cardiorespiratory variables collected during (i) a maximal effort cycle test, (ii) a multi stage submaximal exercise cycle test, and (iii) a dual stage treadmill walking test, performed on separate days.
  2. Lower limb Muscular Strength and Endurance will be assessed from maximal muscle force, maximal muscle power and muscle endurance using pneumatic resistance machines (leg press, knee extension) and free weights (hip abduction, ankle dorsiflexion).
  3. Mobility Variables:

Temporal (velocity, step time, single support, double support) and spatial (step length and stride length) variables will be collected using a gait analysis system. Balance in standing and coordinated stability will be assessed using a sway-meter that measures displacements of the body at the level of the waist.

  1. Scales and Questionnaires:

To provide an assessment of changes in the subjects' psychological and functional states, a stroke impact scale, a self-efficacy scale and the health-related quality of life questionnaire will be used.

Data Analysis:

Treatment efficacy for the primary and secondary outcomes will be analyzed using univariate and multivariate analysis of variance. Where within-group differences are found, appropriate multiple comparisons a posteriori analyses will be used. If significant multivariate effects are evident, the standardized discriminant function coefficients will be examined to give an indication of the relative importance of each variable in explaining the variance in the group by time effect. To allow for the possibility that all or some of these data may be covariates upon the primary outcome, multiple regression analysis will be utilized to explore the relative importance of aerobic fitness, muscle power, strength or endurance and mobility measures upon 6-min walk distance.

Conditions
Stroke
Being tested
[A] Aerobic isokinetic cycling exercise, [B] Progressive Resistance Training, [A] + [B]
Keywords
Stroke, Exercise, Aerobic, PRT, Walking ability
Medical subject headings
Stroke, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • [A] Aerobic isokinetic cycling exerciseProcedure or surgery

  • [B] Progressive Resistance TrainingProcedure or surgery

  • [A] + [B]Procedure or surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Subjects will undertake a 6 min walking test for maximum distance

Secondary outcomes (4)
  1. Cardiorespiratory Fitness

  2. Lower limb muscular strength and endurance

  3. Mobility variables

  4. Scales and questionnaires

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Apr 2005 (estimated)
  2. Study startJan 2001
  3. Primary completionMar 2003
  4. Study completionMay 2004

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Masking
Double blind
Enrolment
48 participants
IDs, dates and publications
ClinicalTrials.gov ID
NCT00107068
Sponsor's protocol ID
NHMRC 153970
Other IDs
NHMRC 153970
Status last verified
Dec 2015
First submitted
4 Apr 2005
Last updated
3 Dec 2015
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing [A] Aerobic isokinetic cycling exercise, [B] Progressive Resistance Training and [A] + [B] in people with Stroke, run by University of Sydney at 1 site in Australia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Dec 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Australia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Subjects will undertake a 6 min walking test for maximum distance. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Dec 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in